Coloplast A/S (ETR: CBHD)

Market Cap	24.06B
Revenue (ttm)	3.62B
Net Income (ttm)	677.46M
Shares Out	n/a
EPS (ttm)	3.01
PE Ratio	35.51
Forward PE	n/a
Dividend	2.95 (2.75%)
Ex-Dividend Date	Dec 6, 2024

Volume	154
Open	106.00
Previous Close	107.20
Day's Range	105.00 - 106.00
52-Week Range	101.60 - 130.95
Beta	0.33
Analysts	n/a
Price Target	n/a
Earnings Date	Feb 4, 2025

About Coloplast

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the B...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1954
• Employees: 16,639
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: CBHD

Financial Performance

In 2024, Coloplast's revenue was 27.03 billion, an increase of 10.33% compared to the previous year's 24.50 billion. Earnings were 5.05 billion, an increase of 5.62%.

Financial numbers in DKK